Wednesday, 16 October 2024
  
Login

Australia's most trusted
source of pharma news

Wednesday, 16 October 2024
News

Best in generics & biosims named

Posted 15 October 2024 PM

Samsung Bioepis has been named the Company of the Year across the Asia Pacific region at the 2024 Global Generics & Biosimilars Awards for a third consecutive year while Sandoz scooped the pool, with three awards yet again.

The 11th annual awards night held in Milan, Italy last week and organised by pharmaceutical industry intelligence provider Citeline, recognises the exceptional achievements in the generics and biosimilars industry worldwide.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (17)

Clinical & Medical, R&D (17)

Regulatory, Pharmacovigilance & QA (7)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.